Phathom Pharmaceuticals, Inc. PHAT Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s other non-current liabilities?
- Phathom Pharmaceuticals, Inc. (PHAT) reported other non-current liabilities of $3.5M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s other non-current liabilities changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s other non-current liabilities decreased by 69.6% year-over-year, from $11.5M to $3.5M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s other non-current liabilities has grown at a -0.6% compound annual growth rate (CAGR), from $4.13M to $4M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.